Gastroenterology
News
FDA approves two vonoprazan therapies for H. pylori eradication
“H. pylori eradication rates continue to decline in part due to antibiotic resistance, inadequate acid suppression, and complex treatment...
Conference Coverage
Bone, breath, heart, guts: Eight essential papers in primary care
Roughly one in three adults with hypertension have inadequate blood pressure control, and clinicians have two options for intensifying treatment,...
Conference Coverage
Single-use endoscopy: Here to stay?
Economic and regulatory factors favor single-use, and companies make a case for its environmental impact.
From the Journals
Cellular gene profiling may predict IBD treatment response
Phagocytic gene expression correlated with inflammatory states, types of IBD, and responses to therapy.
From the Journals
‘Forever chemicals’ linked to liver damage
“PFAS are similar to fatty acids in chemical structure, so it’s possible that they activate some of the same receptors or otherwise interfere with...
From the Journals
Deep learning system outmatches pathologists in diagnosing liver lesions
The system could eventually be used to optimize accuracy and efficiency of histologic diagnoses, potentially decreasing reliance on pathologists...
From the Journals
POEM use for achalasia growing, reimbursement urged
“It is critical for clinicians incorporating POEM into their practice to be transparent with patients about the tradeoffs between the available...
News from the FDA/CDC
Upadacitinib earns FDA approval for ankylosing spondylitis
Janus kinase inhibitor offers oral option for patients who have who have had an insufficient response or intolerance with one or more tumor...
Guidelines
New guideline sheds light on diagnosis, treatment of rare GI syndromes
The U.S. Multi-Society Task Force on Colorectal Cancer provides 14 recommendations for the genetic evaluation, surveillance, and treatment of...
Conference Coverage
IBD risk ‘uncertain’ in biologic-treated AxSpA patients
“Enormous uncertainty” surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial...
From the Journals
Liquid biopsy a valuable tool for detecting, monitoring HCC
Further research is needed to overcome barriers to routine clinical use, such as the lack of standardization in the collection process.